1. Home
  2. PRSO vs PFSA Comparison

PRSO vs PFSA Comparison

Compare PRSO & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.98

Market Cap

9.8M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.20

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRSO
PFSA
Founded
2008
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8M
11.1M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
PRSO
PFSA
Price
$0.98
$0.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
932.8K
7.7M
Earning Date
11-10-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,001,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
122.22
52 Week Low
$0.52
$0.12
52 Week High
$2.37
$12.76

Technical Indicators

Market Signals
Indicator
PRSO
PFSA
Relative Strength Index (RSI) 45.70 N/A
Support Level $0.92 N/A
Resistance Level $1.05 N/A
Average True Range (ATR) 0.07 0.00
MACD 0.03 0.00
Stochastic Oscillator 70.87 0.00

Price Performance

Historical Comparison
PRSO
PFSA

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: